[Elsevier] 50P Efficacy and safety of pemigatinib in Chinese patients with unresectable, advanced/ recurrent or metastatic intrahepatic cholangiocarcinoma with FGFR2 fusion or rearrangement that failed to prior systemic therapy

Wardarasoolisb Post time The day before yesterday 06:20 | Show all posts |Read mode
Reward10points

journal:Annals of Oncology

Authors:G-M. Shi; X-Y. Huang; T-F. Wen; T-Q. Song; M. Kuang; H-B. Mou; L-Q. Bao; H-T. Zhao; H. Zhao; X-L. Feng; B. Zhang; T. Peng; Y. Zhang; X. Li; H. Yu; Y. Cao; Y. Luo; Y. Wang; J. Fan; J. Zhou

Published date:2021-9-

DOI:10.1016/j.annonc.2021.08.329

PDF link:https://www.sciencedirect.com/sc ... 923753421025588/pdf

Article link:http://dx.doi.org/10.1016/j.annonc.2021.08.329

Article Source:Elsevier BV


Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
PIK-CM Post time The day before yesterday 06:20 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    240

Latest Reply

Return to the list